Natalizumab/ocrelizumab

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: 2 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Toorop A, et al. Mild disease course of carry-over progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab. Multiple Sclerosis Journal 26 (Suppl. 3): 537 (plus poster) abstr. P0881, Dec 2020. Available from: URL: http://doi.org/10.1177/1352458520974937 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Natalizumab/ocrelizumab. Reactions Weekly 1842, 280 (2021). https://doi.org/10.1007/s40278-021-91016-8

    Download citation